According to the data obtained from both GEPIA2 and UALCAN, we found elevated transcriptional expression levels of CBX2/3/5/8, while reducing levels of CBX6/7 in GBM tissues vs. normal tissues. This evidence concerns the gene CBX6 and glioblastoma.